|
Through a leveraged
buy-out, the Funds acquired 100% of the Medicor Group, the largest
manufacturer and distributor of medical instruments and hospital
equipment -- such as handheld surgical tools, disposable needles,
plastic drips/tubes, electrical diagnostic equipment, operating
theater equipment etc. -- in Central/Eastern Europe. Medicor is
the dominant supplier in the domestic market, and exports a significant
portion of its production to the USA, Germany, Brazil, and Russia
among others.
Strong
export-led revenue growth is expected to continue over the next few
years, as even greater emphasis is placed on marketing,
brand building and the penetration of new markets. MAVA also aims
to exploit the substantial potential for enhancing efficiency and
effectiveness in the production, service and functional arenas to
turn Medicor into a dynamic technology based medical hardware and
software company.
The operating
cash flows of the Group along with the sale of a non-core subsidiary
allowed our investors to recoup a significant amount of their
investment within 2 years of the acquisition. Medicor is well poised
to exploit the expected demand for medical supplies in Central &
Eastern Europe and Russia.
|